ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 0645

Mortality and Ethnicity in Adults with Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Analysis

Samir Patel1, Zijing Yang1, deepak Nagra1, Maryam Adas2, Mark Russell1, Sam Norton1, Chris Wincup3, James Galloway4, Kate Bramham2 and Patrick Gordon5, 1King's College London, London, England, United Kingdom, 2King's College London, London, United Kingdom, 3King's College Hospital, London, United Kingdom, 4Centre for Rheumatic Diseases, King's College London, London, United Kingdom, 5nhs, London, United Kingdom

Meeting: ACR Convergence 2024

Keywords: Epidemiology, Mortality, race/ethnicity, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Ethnicity and health outcomes are intrinsically interrelated, although mechanisms are complex. Systemic lupus erythematosus (SLE) is a disease with higher incidence in non-White populations and associated with premature mortality. Survival is thought to vary across ethnicities in patients with SLE; however, there has not been a comprehensive review or meta-analysis demonstrating this. Thus, we aimed to investigate the association between ethnicity and mortality in patients with SLE.

Methods: We performed a systematic literature search of the databases MEDLINE, Embase and the Cochrane Library, from inception to 31 December 2023. Search terms included systemic lupus erythematosus, ethnicity, race, mortality and synonyms. Study eligibility criteria were cohort studies and trials that reported on the mortality of adults >16 years old with SLE. We used a pairwise meta-analysis to determine the pooled odds ratio of death for those from Black, Asian, Hispanic or Indigenous ethnic groups compared to those of White ethnicity, recognising that non-White ethnicities represented underserved populations.

Results: Forty studies, comprising 92,079 patients with SLE were included (Figure 1). Overall, non-White ethnicity was significantly associated with death compared to White ethnicity (OR 1.15 [95% CI: 1.01-1.32]; Figure 2). On subgroup analysis, mortality was higher in Black patients (OR 1.30 [95% CI: 1.16-1.46]) and Indigenous patients (OR 1.45 [95% CI: 1.10-1.89]), whilst Asian and Hispanic patients showed no significant differences compared to White patients with SLE (Table 1). Meta-regression found no associations between study effect size, length of follow-up or mid-year point. The association between ethnicity and mortality in patients with SLE did not appear to change over time. Sixty-five percent of included studies were conducted in the United States of America (USA) and when excluded, the significant difference in mortality between Black and White individuals with SLE was no longer seen (OR 0.84 [95% CI: 0.54-1.31]; Table 1).

Conclusion: Patients with SLE from Black or Indigenous ethnicities had higher mortality than those from White ethnicities. This could be driven by several complex and diverse factors such as structural racism, associated socioeconomic deprivation, healthcare accessibility, differing cultural beliefs or more severe SLE phenotypes in these ethnic groups. However, on sensitivity analyses we observed inconsistencies between USA and non-USA cohorts regarding the association of Black ethnicity and mortality, though a scarcity of data outside of the USA was noted. Recent national data from the USA described higher mortality in the general Black and Indigenous American population compared to the White American population, suggesting a wider systemic issue which may be reflected in, but not limited to, patients with SLE. Until more generalisable data outside of the USA are available, we promote caution in the use of ethnicity as a risk factor for mortality.

Supporting image 1

Figure 1. PRISMA flow diagram of literature search and study inclusion

Supporting image 2

Figure 2. Association between ethnicity and mortality in patients with SLE. White ethnicity was used as the reference group for all comparisons. Weights are from random-effects analyses. Bars indicate 95% confidence intervals (CI).

Supporting image 3

Table 1. Pooled odds ratio (OR) of death in patients with SLE across ethnicities and country. CI: confidence intervals.


Disclosures: S. Patel: None; Z. Yang: None; d. Nagra: None; M. Adas: None; M. Russell: AbbVie, Biogen, Lilly, Galapagos, Menarini, UCB, Viforpharma, 6, Sandoz UK, 5; S. Norton: None; C. Wincup: Versus Arthritis, Lupus UK, Astrazeneca and British Society for Rheumatology, 5; J. Galloway: AbbVie, 6, AstraZeneca, 5, Galapagos, 2, 6, Janssen, 2, 5, 6, Lilly, 2, 6, Pfizer, 2, 5, 6, UCB, 6; K. Bramham: None; P. Gordon: Alexion, 12, Primary investigator at King's college hospital for the NCT04999020 study (ALXN1210-DM-310). No personal payment, Argenx, 12, PI at King's College Hospital for study ARGX-113-2007 and Study ARGX-113-2011, Bristol-Myers Squibb(BMS), 12, POETYK SLE study (NCT05620407), Chief investigator for UK and site PI at King's College Hospital London for this study ., Celltrion Healthcare, 12, Funded to attend EULAR convergence in 2023, Eli Lilly, 12, PI at King's College Hospital for MOJAK, funded by Eli Lilly with University of Manchester as the Sponsor. Termination date aproximate, Galapagos, 1, 2, 12, Chief investigator in UK for Galarisso study (NCT05695950).

To cite this abstract in AMA style:

Patel S, Yang Z, Nagra d, Adas M, Russell M, Norton S, Wincup C, Galloway J, Bramham K, Gordon P. Mortality and Ethnicity in Adults with Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Analysis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/mortality-and-ethnicity-in-adults-with-systemic-lupus-erythematosus-a-systematic-literature-review-and-meta-analysis/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mortality-and-ethnicity-in-adults-with-systemic-lupus-erythematosus-a-systematic-literature-review-and-meta-analysis/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology